期刊文献+

小剂量替勃龙对围绝经期及绝经后妇女颈动脉粥样硬化的影响 被引量:5

原文传递
导出
摘要 心脑血管疾病是中老年患者的主要死亡原因。围绝经期及绝经后妇女体内的性激素水平迅速下降,使血脂代谢异常,导致围绝经期及绝经后妇女心脑血管疾病的发病率增高。目前,雌激素对于预防女性冠心病的作用尚有争议,本研究目的是通过比较应用小剂量替勃龙与未应用替勃龙的围绝经期及绝经后妇女体内的性激素、血脂水平以及颈动脉血流超声影像学特征,探索理想、有效的低剂量激素治疗方案,达到降低中老年妇女心血管疾病的发生率和死亡率、改善生命质量、预防疾病的目的。
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2010年第6期452-454,共3页 Chinese Journal of Obstetrics and Gynecology
  • 相关文献

参考文献6

  • 1李健初,袁光滑,柳文仪,等.血管和浅表器官彩色多普勒超声诊断学.3版.北京:北京医科大学协和医科大学联合出版社,1999:133.
  • 2Vrablik M,Fait T,Kovar J,et al.Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.Metabolism,2008,57:1088-1092.
  • 3Christodoulakos GE,Lambrinoudaki IV,Economou EV,et al.Differential effect of hormone therapy and tibolone on lipids,lipoproteins,and the atherogenic index of plasma.Cardiovasc Pharmaco1,2006,47:542-548.
  • 4Rasulo FA,De Peri E,Lavinio A.Transcranial Doppler ultrasonography in intensive care.Eur J Anaesthesiol Suppl,2008,42:167-173.
  • 5Carranza-Lira S,Cuan-Martinez JR,Rosales-Ortiz S.Brachial artery responses in menopausal women using tibolone.Int J Gynecol Obstet,2008,101:43-46.
  • 6Seeger H,Kloosterboer HJ,Studen M,et al.In vitro effects of tibolone and its metabolites on human vascular coronary cells.Maturitas,2007,58:42-49.

同被引文献39

  • 1谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 2O'Keefe JH,Kim SC,Hall RR,et al.Estrogen replacement after coronary angioplasty in women.[J].Am Coll Cardiol,1997,29:1-5.
  • 3Walera DD,Alderman EL,Hsia J,et al.Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary athemsclemsis in postmenopausal women:a randomized controlled trial[J].JAMA,2002,288 (19):2432-2440.
  • 4Ziaei S,Moghasemi M,Faghihzadeh S.Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women[J].Climacteric,2010,13 (2):147-156.
  • 5Nijland EA,Weijmar-Sehuhz WC,Nathorst-Boos J,et al.Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women:results of a randomized active-controlled trial[J].Sex Med,2008,5 (3):646-656.
  • 6Sanjuan A,Castelo-Branco C,Colodrbn M,et al.Effects of estradiol,cyproterone acetate,tibolone and raloxifene on uterus and aorta atherosclerosis in oophorectomized cholesterol-fedrabbits[J].Maturitas,2003,45 (1):59-66.
  • 7Christodouhkos GE,Iambrinoudaki IV,Economou EV,et al.Differential effect of hormone therapy and tibolone on lipids,lipoproteins,and the atherogenic index of plasma[J].Cardiovasc Pharmacol,2006,47 (4):542-548.
  • 8Lazzeroni M,Macis D,Decensi A,et al.The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial[J].Ecancermedicalscience,2008,2:67.
  • 9Campisi R,Marengo FD.Cardiovascular effects of tibolone:a selective tissue estrogenic activity regulator[J].Cardiovasc Drug Rev,2007,25:132-145.
  • 10Ribeiro F,Alves AJ,Teixeira M,et al.Endothelial function and atherosclerosis:circulatory markers with clinical usefulness[J].Rev Port Cardiol,2009,28 (10):1121-1151.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部